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Endovascular treatment of embolization of aortic
plaque with covered stents
Matthew J. Dougherty, MD, and Keith D. Calligaro, MD, Philadelphia, Pa
Spontaneous atheroembolization from aortic plaque can lead to organ dysfunction and limb loss. With discrete offending
lesions, surgical treatment has been recommended. Although endovascular treatment with angioplasty or stenting has
been reported, concerns about destabilizing atheromatous material with catheter manipulation are well founded. Covered
stents may obviate this risk. We report herein two patients with embolizing infrarenal aortic plaque successfully treated
with these devices. (J Vasc Surg 2002;36:727-31.)
Spontaneous atheroembolization from complex ath-
erosclerotic plaque of the abdominal aorta can result in
gangrene and major amputation. With localized offending
plaque, surgical replacement has been advocated because
endovascular manipulations are perceived to be risky in this
setting.1-3 We report herein two cases of aortic atheroem-
bolization syndrome successfully treated with covered
stents.
CASE REPORTS
Case 1. An obese nonsmoking 67-year-old woman with hy-
percholesterolemia and a remote history of endometrial cancer,
anticardiolipin antibody syndrome, and resolved left hemispheric
stroke was seen with an 8-week history of the abrupt onset of
painful cyanotic toes in both feet. Examination revealed normal
pulses to the pedal level bilaterally. Mottling with digital cyanosis
was present in all digits, with right worse than left. Frank dry
gangrene to the proximal phalangeal level was noted in the right
second through fourth toes.
Arteriography showed no proximal arterial occlusions; how-
ever, multifocal occlusions were noted at the inframalleolar level
(Fig 1). Irregular plaque with ulceration was noted at the infrarenal
aorta, which was small in caliber at 12 mm (Fig 2).
Because of the patient’s severe obesity and other comorbidi-
ties, aortic replacement was believed to carry substantial risk and
endovascular treatment with a Wallgraft (Meditech, Boston Scien-
tific, Natick, Mass) was elected. Aspirin therapy was initiated
before the procedure and continued after surgery. An open ap-
proach was elected because of the small vessel size relative to the 9F
sheath necessary. With regional anesthesia, a 14 mm by 4 cm
Wallgraft was primarily deployed over a guidewire (Fig 3). Balloon
angioplasty was performed after the stent graft was deployed.
Completion aortography showed a smooth contour to the in-
volved aortic segment (Fig 3, B).
The patient subsequently underwent interphalyngeal amputa-
tions of the right second through fifth digits (Fig 4). The severe
pedal pain resolved within 3 months, and the stent graft has
remained patent through a follow-up period of 16 months with no
subsequent embolic episodes.
Case 2. A 58-year-old woman who was a former smoker with
diabetes mellitus and hypertension was seen with painful cyanosis
involving multiple toes bilaterally that developed abruptly 4 weeks
previously. Five months previously, the patient underwent cardiac
catheterization and coronary bypass uneventfully, with no lower
extremity symptoms. Examination revealed palpable pulses to the
pedal level. Livedo reticularis with gangrenous changes were evi-
dent at the distal right first and second digits and the left fifth digit
(Fig 5).
Arteriography revealed an ulcerated infrarenal plaque in the
small-caliber aorta (Fig 6), with minimal other significant athero-
sclerotic changes. Inframalleolar arterial occlusions were also
noted.
The patient underwent Wallgraft deployment with the same
technique described in case 1. Prompt resolution of the pain and
healing of the toe lesions followed, and the patient remains free of
further embolic episodes through 10 months of follow-up. Patency
and satisfactory positioning of the stent graft has been shown on
color duplex scan.
DISCUSSION
Atheroembolization syndrome is a well-recognized en-
tity. Characterized by the development of multifocal mi-
croinfarction of visceral organs and especially the lower
extremities, the clinical process occurs from spontaneous or
iatrogenic disruption of atherosclerotic plaque. This results
in distal embolization of cholesterol crystals, platelet and
fibrin thrombi, and other contents of complex atheroma-
tous plaques.4-8 The pattern of ischemia induced is charac-
teristic, with painful cyanotic or gangrenous changes in the
toes (the “blue toe” syndrome), a livedo reticularis pattern
of mottling of the skin of the lower extremities, and, when
the offending plaque is in the proximal aorta, renal failure
and intestinal infarction.
When atheroembolization syndrome occurs after ma-
nipulation of diseased arteries, such as with vascular surgery
or intraarterial catheterization procedures, supportive
treatment is often sufficient and repeat embolic episodes are
uncommon in the absence of further arterial trauma.5
However, when spontaneous atheroembolization occurs,
which is less common than the iatrogenic type, recurrent
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embolic episodes and progressive tissue loss are likely.9-11
Anticoagulation therapy with heparin and warfarin has
generally not been effective and may in fact be harmful
because it may destabilize the fibrinous cap of complex
atherosclerotic ulcers.4,12 Antiplatelet therapy has been
advocated but is of unproven efficacy.13 When the source of
the embolization is focal and amenable to treatment, it
should be addressed to prevent further embolic epi-
sodes.1,4,14
The most common source for peripheral atheroembo-
lization is the aorta, and when bilateral lower extremity
involvement occurs without renal and visceral involvement,
the infrarenal aorta can be presumed to be the source.15
Arteriographic findings are not always impressive, and de-
tailed imaging is critical. The goal of therapy is to safely
remove the offending atherosclerotic plaque from the arte-
rial bloodstream. Given the frequent instability of these
lesions, surgical treatment has been perceived as safer than
endovascular approaches because the surgeon can clamp
the artery proximal or distal to the lesion to arrest antegrade
flow while manipulating the diseased vessel. Endarterec-
tomy or graft replacement has been the approach most
used.1,16 In patients who are at high risk for major surgery,
a fairly common scenario in this population, extraanatomic
bypass with ligation of the external iliac arteries has been
advocated.1,2
Anecdotal experience and a few small published series
have shown that transluminal angioplasty can sometimes be
used to sufficiently treat embolizing lesions.14,17 The re-
modeling process that occurs with balloon injury theoreti-
cally results in stabilization of the ulcerated atherosclerotic
plaque. Stent placement may provide a protective scaffold
to help secure these lesions. In their report on stent place-
ment for blue toe syndrome in 15 patients, Matchett et al18
reported no procedure-related embolization and only one
patient had recurrent emboli in follow-up. However, as
vascular surgeons attest, the atheromatous paste sometimes
encountered within these plaques can be expected to dis-
rupt with transluminal pressure and extrude through stent
interstices. The risk of periprocedural reembolization is a
serious concern and has limited the application of these
techniques.
The commercial availability of the Wallgraft covered
stent has led to its off-label use within the vascular system
with generally favorable results.19-22 This self-expanding
device can be primarily deployed rapidly over a guidewire.
Balloon angioplasty can then be performed with the stent
graft in place. Although available devices for endovascular
aortic aneurysm repair have large delivery systems and
necessitate multistep deployment, immediate exclusion and
Fig 1. Occlusions of pedal vasculature by small emboli (ar-
rows).
Fig 2. Complex atherosclerotic plaque in infrarenal aorta.
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stabilization of atheromatous material can be accomplished
with minimal arterial manipulation with this low-profile
delivery system. Significant length changes occur with the
Wallgraft with varying vessel diameter, so precise measure-
ment and adjustment during deployment are critical, espe-
cially when landing near the aortic bifurcation as in the
cases reported. The largest diameter Wallgraft currently
available is only 14 mm. This limits its applicability to
patients with small aortic caliber, such as the two female
patients who comprise this case report, or to iliac and
femoral arteries. With rapid evolution and improvement of
endovascular technologies, larger devices with smaller de-
livery systems, such as the Aneurex extension cuff
(Medtronic, Minneapolis, Minn), are becoming available.
Although long-term durability of covered stents in the
aortic position is not yet proven, the risks of late failure
seem intuitively to be considerably less than for endografts
for aneurysmal disease. Migration has been infrequent with
stents in general, and late stenosis has been uncommon in
larger caliber, high-flow arteries treated with stents.23,24 In
nonaneursymal vessels, there is no issue of endoleaks.
More diffuse atherosclerotic disease associated with
recurrent microembolization remains a major challenge for
Fig 3. A, Wallgraft deployed. B, Completion aortogram.
Fig 4. Healed digital amputations at 12 months. Livido reticu-
laris pattern persists.
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Fig 5. Blue toe syndrome with digital gangrene.
Fig 6. A, Aortic plaque with shallow ulcer. B, Exclusion with Wallgraft.
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which current therapies are suboptimal.5 Progressive loss of
renal function, need for amputation, and poor survival are
the rule. In this scenario, the mortality rate approaches
80%.9 The concept of extensive exclusion of diseased aortic
segments with covered stents is attractive. Our current
approach is to consider this strategy when anatomy is
suitable for both patients at good and at poor risk.
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